Last news
Lanvin Group and Primavera Capital Acquisition Corporation Announce Shareholder Approval of Business Combination; Trade Debut Expected on NYSE on December 15 Under Ticker "LANV"

Lanvin Group and Primavera Capital Acquisition Corporation Announce Shareholder Approval of Business Combination; Trade Debut Expected on NYSE on December 15 Under Ticker "LANV"

...

Moomoo SG observes asset influx to wealth management, Group's AUM hits SGD 5.27B

Moomoo SG observes asset influx to wealth management, Group's AUM hits SGD 5.27B

...

On Show! | Year in Year out: Celebrating Chinese Spring Festival -- Invitational Exhibition of the 2023 Global Zodiac Design Competition (Guimao Year of the Rabbit) and Award-winning Works Tour Exhibition Officially Kicked off

On Show! | Year in Year out: Celebrating Chinese Spring Festival -- Invitational Exhibition of the 2023 Global Zodiac Design Competition (Guimao Year of the Rabbit) and Award-winning Works Tour Exhibition Officially Kicked off

...

JinkoSolar's High-efficiency N-Type Monocrystalline Silicon Solar Cell Sets Our New Record with Maximum Conversion Efficiency of 26.4%

JinkoSolar's High-efficiency N-Type Monocrystalline Silicon Solar Cell Sets Our New Record with Maximum Conversion Efficiency of 26.4%

...

Five Types of Shoppers You'll Find This Holiday Season (and the Cyberscams They Must Watch Out For)

Five Types of Shoppers You'll Find This Holiday Season (and the Cyberscams They Must Watch Out For)

...

Being the Top Property in Ubud, Now Kaamala Resort Pampers Honeymooners with Intimate and Different Special Perks

Being the Top Property in Ubud, Now Kaamala Resort Pampers Honeymooners with Intimate and Different Special Perks

...

Asieris Enrolled First Patient for its Phase II Clinical Study of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer

Asieris Enrolled First Patient for its Phase II Clinical Study of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer

...

EQT included in the Dow Jones Sustainability Index

EQT included in the Dow Jones Sustainability Index

...

menu
menu